| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3K | — | +185.1% |
| R&D Expense | $130K | — | +5798.9% |
| SG&A Expense | $1.5M | — | -5.6% |
| Operating Income | -$1.8M | — | -9.5% |
| Interest Expense | $3K | — | -26.7% |
| Pre-tax Income | -$1.8M | — | -9.4% |
| Net Income | -$1.8M | — | -9.4% |
| EPS (Basic) | -$0.63 | — | +35.1% |
| EPS (Diluted) | -$0.63 | — | +35.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $0 | — | — |
| Accounts Receivable | $4K | -47.4% | -55.3% |
| Current Assets | $7.7M | +30.8% | -26.5% |
| Total Assets | $9.6M | +23.1% | -22.2% |
| Current Liabilities | $491K | -18.7% | -9.1% |
| Total Liabilities | $656K | -17.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | -11.6% |
| Capital Expenditures | $2K | — | -69.6% |
| Investing Cash Flow | -$64K | — | -34.3% |
| Financing Cash Flow | $3.6M | — | +8.6% |
| Free Cash Flow | -$1.6M | — | -11.2% |
| -27.5% |
| Stockholders' Equity | $8.9M | +27.7% | -21.7% |